Abstract
Alcohol consumption is widespread with over half of the individuals over 18 years of age in the U.S. reporting alcohol use in the last 30 days. Moreover, 9 million Americans engaged in binge or chronic heavy drinking (CHD) in 2019. CHD negatively impacts pathogen clearance and tissue repair, including in the respiratory tract, thereby increasing susceptibility to infection. Although, it has been hypothesized that chronic alcohol consumption negatively impacts COVID-19 outcomes; the interplay between chronic alcohol use and SARS-CoV-2 infection outcomes has yet to be elucidated. Therefore, in this study we investigated the impact of chronic alcohol consumption on SARS-CoV-2 anti-viral responses in bronchoalveolar lavage cell samples from humans with alcohol use disorder and rhesus macaques that engaged in chronic drinking. Our data show that in both humans and macaques, the induction of key antiviral cytokines and growth factors was decreased with chronic ethanol consumption. Moreover, in macaques fewer differentially expressed genes mapped to Gene Ontology terms associated with antiviral immunity following 6 month of ethanol consumption while TLR signaling pathways were upregulated. These data are indicative of aberrant inflammation and reduced antiviral responses in the lung with chronic alcohol drinking.
Keywords: Alcohol, SARS-CoV-2, lung, non-human primate, scRNA-seq, inflammation
Introduction
Alcohol consumption is widespread in the United States, with 55% of the American population over 18 years of age reporting alcohol use within the last 30 days. Alarmingly, 25% and 6.3% of adults over 18 years of age are classified as binge or heavy drinkers, respectively (National Survey on Drug Use and Health 2020). Both binge and heavy drinking can contribute to acquiring an Alcohol Use Disorder (AUD) diagnosis, defined as the inability to control or cease alcohol use despite experiencing negative social, occupational, or health-related consequences (1). In 2019, 9 million men and 5.5 million women were diagnosed with AUD (2). Excessive alcohol consumption impairs lung (3), liver (4), pancreas (5), spleen (6), and heart (7, 8) function. Alcohol consumption is also associated with increased incidence of cancers (9–11). Moreover, excessive alcohol consumption leads to an increased rate (12) and length of hospitalizations (13) including to the intensive care unit (14). Individuals with AUD are also at increased risk of nosocomial infections following trauma (15) and wound-related infections (16). Overall, excessive alcohol use in the United States is associated with a $249 billion loss to the American economy (17) and $28 billion in healthcare-related costs (17, 18). Moreover, it is also associated with more than 260 alcohol-related deaths per day, making AUD the third leading cause of preventable deaths in the United States (19).
Data from clinical and experimental studies indicate that chronic excessive alcohol consumption disrupts cellular mechanisms responsible for pathogen clearance and tissue repair (20, 21), leading to increased susceptibility to infection and delayed wound healing (22, 23). Specifically, the incidence of K. pneumonia, S. pneumonia, Mycobacterium tuberculosis infection, hepatitis C virus, and respiratory syncytia virus (RSV) are increased with chronic heavy drinking (CHD) (23–25). Animal model studies have recapitulated the increased severity of bacterial and viral infections with CHD further highlighting the immunological basis of these adverse outcomes (26, 27).
Underlying mechanisms driving poor infectious disease outcomes are the focus of several studies that have reported hyper-inflammatory responses following LPS stimulation by circulating and tissue-resident myeloid cells from humans with or animal models of CHD (3, 28). In contrast, stimulation with pathogens decreased the production of key immune mediators (3, 29, 30). A dysregulation of phagocytic capacity within myeloid populations has also been observed in conjunction with CHD (31, 32). Additionally, in-vitro ethanol treatment of monocytes resulted in lower expression levels of MHC-II molecules (33), suggesting that CHD can lead to reduced antigen presentation capacity. Similarly, excessive alcohol consumption interferes with the phagocytic capacity of alveolar macrophages (AM) and their ability to generate anti-viral and anti-bacterial responses (34–36). Alcohol exposure in rats dampens the expression of GM-CSF receptors required for the differentiation of monocytes into macrophages upon infiltrating the lungs (34, 37). In addition to impairing immune responses, CHD decreases barrier function in the respiratory tract, increasing susceptibility to respiratory infections (38). Individuals with CHD are at increased risk of developing acute respiratory distress syndrome (ARDS) (39), leading to organ failure, sepsis, or death (40).
The shelter-in-place orders associated with the COVID-19 pandemic led to increased alcohol consumption in the United States (41). Given the impact of chronic ethanol consumption on the respiratory system, it has been hypothesized that increased ethanol consumption could be one of the drivers for COVID-19 severity (42). However, the interplay between chronic ethanol consumption and the anti-viral response to SARS-CoV-2 remains poorly understood. Therefore, in this study, bronchial alveolar lavage (BAL) cell samples obtained from rhesus macaques before and after 6-months of voluntary ethanol self-administration, as well as those obtained from individuals with and without AUD were infected ex vivo with SARS-CoV-2. Response to infection was monitored by measuring immune mediator release and transcriptional changes using single cell RNA sequencing (scRNA-Seq).
Materials and Methods
See the data supplement for detailed methods.
Sample collection
Bronchoalveolar lavage (BAL) samples were collected from 5 male and 6 female rhesus macaques (6 low drinkers, 4 heavy drinker, and 1 very heavy drinker) at baseline (before induction) and after 6 months of chronic consumption (Table 1) (Cohort 18 on matrr.com) (43, 44).
Table 1:
Demographics of the NHP cohort utilized in this study.
ID | Sex | Drinking Phenotype | Mean daily ethanol intake (g/kg/day) | Average Blood Ethanol Content (Avg mg%) |
---|---|---|---|---|
10331 | F | LD | 0.5 | 0 |
10332 | F | LD | 1.23 | 3.15 |
10334 | F | LD | 1.78 | 24.32 |
10339 | F | LD | 1.74 | 30.42 |
10340 | F | VHD | 3.53 | 40.24 |
10333 | F | HD | 3.04 | 46.01 |
10341 | M | LD | 1.94 | 32.64 |
10335 | M | LD | 1.32 | 16.78 |
10337 | M | VHD | 4.02 | 158.62 |
10338 | M | VHD | 5.93 | 209.11 |
10342 | M | VHD | 4.04 | 161.72 |
Human BAL samples and informed written consent were obtained, after IRB approval, from the University of Colorado School of Medicine’s Colorado-Pulmonary Alcohol Research Collaborative (CoPARC) (https://medschool.cuanschutz.edu/coparc) (Table 2).
Table 2:
Demographic information from the human BAL samples utilized in this study.
Smoking n=3 |
Smoking and Alcohol Consumption n=3 |
|
---|---|---|
| ||
Age (years) | 54.7 ± 6.1 | 58.0 ± 2.6 |
| ||
Sex | Males: 3 | Males: 3 |
Females: 0 | Females: 0 | |
| ||
Race | ||
African American | 1 | 1 |
White | 1 | 1 |
Hispanic | 1 | 1 |
Bronchoalveolar Lavage (BAL) Cell Isolation
BAL samples were centrifuged at 2000 rpm for 10 minutes. Pellets were resuspended in 10% DMSO/FBS solution, stored in a Mr. Frosty Freezing container (Thermo Fisher Scientific) at −80C for 24 hours, and then transferred to a cryogenic unit for long-term storage.
Flow Cytometry
BAL cells were thawed, stained with the specified antibodies, acquired using an Attune NxT Flow Cytometer, and analyzed using the FlowJo software.
SARS-CoV-2 Infection
1×106 live BAL cells were infected with SARS-CoV-2 (Washington isolate) at an MOI of 1 or left untreated for 24 hours at 37°C, 5% CO2. At the end of the infection, supernatants were stored at −80C for Luminex analysis while cells were processed for single cell RNA sequencing.
Luminex
Immune mediators were measured in NHP samples via an 36-plex NHP XL Cytokine Premixed Kit (R&D) and in human samples via a customized human 29-plex (R&D). The samples were analyzed on a MAGPIX instrument (Luminex).
Single Cell RNA library preparation
Live BAL cells were sorted and labeled with cell multiplexing oligos per manufacturer instructions (10X Genomics) then loaded into a 10x Genomics Chromium Controller. The libraries were prepared using the v3.1 chemistry Single Cell 3’Feature Barcoding Library Kit (10x Genomics) according to the manufacturer’s instructions.
Single cells RNA Sequencing Analysis
Libraries were sequenced using a NovaSeq6000. The reads were aligned and quantified against the Mmul_8 rhesus macaque reference genome or the human genome GRCh38. Downstream analysis was performed using Seurat multi-function (version 4.1.1). Samples were de-multiplexed (45), normalized, and integrated. A PCA was generated to determine the dimensionality of the data set and a UMAP was generated and cell clustering was performed. Differential gene expression analysis and functional enrichment were performed using MAST and Metascape, respectively (46).
Data availability
The datasets utilized in this article are available on NCBI’s Sequence Read Archive PRJNA930878 (NHP) and PRJNA930381 (Human).
Statistical Analysis
Statistical analyses were carried out using GraphPad Prism 9.
Results
Chronic heavy drinking skews the lung environment towards a heightened inflammatory state
To understand the impact of chronic ethanol consumption on the immunological landscape of the lung, BAL samples were collected from male and female rhesus macaques before and after 6 months of daily voluntary ethanol self-administration (Table 1) and subjected to flow cytometry (Figure 1A, Supp Figure 1 A, B). This analysis revealed that at baseline the relative abundance of CD8 and CD4 T cells was significantly higher in females compared to males (Supp Figure 1C). In contrast, the frequency of B cells was higher in males than females at baseline (Supp Figure 1D). Following 6 months of ethanol self-administration, the frequency of CD8 T cells was significantly reduced in females while that of natural killer (NK) cells was significantly reduced in males (Supp. Figure 1C, E). Conversely, the relative abundance of alveolar macrophages (AM) was increased in both males and females (Supp. Fig 1F). This increase was primarily mediated by an expansion of activated AM (CD163+), and a decrease in interstitial macrophages (IM) (Supp. Fig 1F, G). The frequency of dendritic cells (DC) also significantly increased after 6 months of CHD in males, whereas the opposite trend was observed in females (Supp. Fig 1H). The frequency of infiltrating monocytes was greater in females than males at baseline but decreased with drinking (Supp. Fig 1I). Nevertheless, ethanol exposure led to an expansion of nonclassical (activated) monocytes and a decrease in classical monocytes in both males and females (Supp. Fig 1I).
Figure 1: Response to SARS-CoV-2 infection is mitigated in rhesus macaques after chronic alcohol consumption.
A) BALs were collected from rhesus macaqus before and after 6 months of drinking to assess the impact of alcohol consumption on SARS-CoV-2 infection. B) Uniform manifold approximation and projection (UMAP) representation of 151, 269 immune cells with and without infection and 6 months drinking. Sixteen unique clusters were determined. C) Bubble plot of key cluster marker genes. Percent of cells that express each transcript is represented by the size of the bubble while the average expression of those cells is denoted by color, ranging from blue (low) to red (high). D) Relative frequency of each cluster before and after infection. Samples within time points were compared in a pairwise fashion. E) Scatter bar plots comparing the Log2 fold change in response to SARS-CoV-2 infection of select cytokine and chemokine concentrations within BAL cell culture supernatants at baseline and after 6 months of open access to alcohol in male and female subjects (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001). F) Feature plot of SARS-CoV-2 expression within the UMAP. G) Bubbleplot of SARS-CoV-2 expression within each cluster stratified by timepoint. Average expression of the SARS-CoV-2 transcript is represented by bubble size while the significance of baseline to 6 months comparison is denoted by color.
We next investigated the impact of chronic ethanol consumption on the transcriptional landscape of immune cells using scRNA-Seq (Figure 1A). A total of 16 unique clusters were identified, including 9 alveolar macrophages (AM) subsets (defined by markers MRC1, FABP4, MARCO), 1 infiltrating monocyte group (CD14), 1 conventional DC subset (MAMU-DRA, BATF3), CD4 and CD8 T cells (CD3D, CD4, GZMB), B cells (MS4A1, CD79B), proliferating cells (MKI67), and epithelial cells (EPCAM, CLDN4) populations (Figure 1B, C). Each cluster was constituted of cells from all subjects, regardless of the time point of collection and SARS-CoV-2 infection (Supp. Fig 2A). The 9 AM clusters were distinct based on several inflammatory and regulatory markers (FABP4, STAT1, CD9.1, MMP10, ISG20, IL1B, CD14, MARCO, LCN2, HYOU1, LYZ, MAMU-DRA) (Supp. Fig 2B).
In line with the data from flow cytometry, the relative abundance of T cells decreased while that of myeloid cells increased following 6 months of ethanol consumption (Figure 1D). Ethanol consumption also resulted in transcriptional shifts in the immune landscape of the lung. Specifically, within myeloid populations (AM, infiltrating monocytes), scores of modules associated with migration were decreased while those associated with hypoxia (HIF1α signaling) and other inflammatory pathways (TLR, viral/bacterial responses) were increased (Supp. Fig 3A). Similarly, genes differentially expressed (DEG) with alcohol consumption in myeloid subsets mapped to GO terms such as response to oxygen levels (HlF-1α), innate immune responses (CD14), and positive regulation of cell migration (IL-1α, IL-1β, MMP14, CD74, MIF) (Supp. Fig 3B, C). Within CD4 and CD8 T cell subsets, scores of modules associated with Th2 and viral/bacterial response signaling pathways were increased with chronic ethanol consumption (Supp. Fig 3A). DEGs in lymphoid populations map to GO terms such as cell killing (GZMB), lymphocyte-mediated immunity (IL-2Rβ, CD40LG), in addition to response to hypoxia (Supp. Fig 3B, C). These data indicate that chronic ethanol consumption alters the frequency and transcriptional profile of BAL-resident immune cells.
Chronic heavy drinking alters the immune mediator response to SARS-CoV-2 infection and distribution of cell subsets
We next assessed the impact of ethanol consumption on immune mediator production in response to SARS-CoV-2 infection (Figure 1A). The increase in the production of immune mediators over no infection condition was comparable between males and females (Supp Table 1) so the data were combined. SARS-CoV-2 infection induced a robust response demonstrated by increased induction of several cytokines, chemokines, and growth factors in culture supernatants at both timepoints relative to non-infection conditions (Figure 1E, Supp. Table 1). Chronic ethanol consumption resulted in an increase in the induction of growth factors BDNF and FGFβ and a modest increase in the induction of inflammatory cytokine TNFα. In contrast, induction of growth factors VEGFA and TGFα, inflammatory cytokines IFNβ and IL-15, T cell activation marker PD-L1, and chemokine CCL2 were significantly decreased after 6 months of drinking (Figure 1E). These results demonstrate that chronic ethanol consumption alters the secrotome in response to viral infection, suggestive of a dysregulated SARS-CoV-2 responses.
We then leveraged scRNA Seq to investigate the impact of chronic ethanol consumption on immune subset distribution and SARS-CoV-2 detection. A pairwise comparison of the relative abundance of clusters after infection showed a significantly reduced frequency of the AM3, AM5, and DC clusters and a notable decrease in the AM7, Mono, CD4, and CD8 clusters at baseline (Figure 1D). After 6 months of ethanol consumption, significant decrease in frequency was evident in AM1 and CD4 clusters, with a notable decrease in the Mono cluster and an increase in the Epithelial cluster was observed in response to SARS-CoV-2 infection (Figure 1D). Additionally, this analysis revealed that myeloid clusters contained a majority of the SARS-CoV-2 transcript, with the AM7 cluster exhibiting the greatest expression (Figure 1F,G). Interestingly, the average expression of SARS-CoV-2 transcripts was significantly decreased across all AM clusters, except AM4 and AM5, after 6 months of ethanol consumption (Figure 1G). In contrast, levels of viral transcripts were increased in the CD4 and CD8 T cell subset after 6 months of chronic ethanol consumption (Figure 1G).
Chronic ethanol consumption alters transcriptional response to SARS-CoV-2
Because SARS-CoV-2 was predominately detected in myeloid cells, we focused our analysis on these clusters. To interrogate the impact of ethanol consumption on the anti-SARS-CoV-2 response, we measured module scores associated with cytokine/chemokine signaling, viral/bacterial response, and toll-like receptor (TLR) signaling (Figure 2A, Supp Table 2). All three module scores increased after SARS-CoV-2 infection at both time points within several myeloid clusters (Figure 2A). After infection, there was a significant increase in module scores of cytokine/chemokine signaling and anti-viral/bacterial responses within more myeloid clusters at baseline, whereas scores associated with TLR signaling were increased within a greater number of clusters after ethanol consumption (Figure 2A). Futhermore, module scores for cytokine/chemokine signaling were significantly lower in AM3, AM4, and Mono at 6mo when compared to baseline after infection. These observations are in line with the decreased induction of IL-15, VEGF, IFNβ and increased induction of TNFa observed in the Luminex analysis (Figure 1E). All three module scores increased in DCs after infection in the samples obtained at baseline whereas a significant increase in the expression of genes only within the anti-viral/bacterial module were noted after 6 onths of ethanol consumption (Figure 2A).
Figure 2: CHD predominately affects how myeloid cells respond to SARS-CoV-2.
A) Heatmap comparing module scores for cytokine/chemokine signaling, viral/bacterial responses, and TLR signaling between samples based on condition and timepoint. The average module score for each cluster ranges from low (blue) to high (red). Significance displayed is relative to non-infected conditions within timepoints, * p ≤ 0.05, ** ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. # denotes significance when comparing infected conditions and & denotes significance when comparing non infected conditions (#/& p ≤ 0.05, && ≤ 0.01). B) Stacked bar graph showing the number of unique and shared DEGs for myeloid clusters. C) Bubble plot of significant and notable gene ontology (GO) terms from functional enrichment of myeloid clusters. D) Heatmap of the average expression of select DEGs in AM clusters across conditions and timepoint. The average expression for each transcript ranges from low (blue) to high (red). E) Heatmap of the average expression of select DEGs in mono clusters across conditions and timepoint. The average expression for each transcript ranges from low (blue) to high (red).
We next performed differential gene expression analysis comparing infected relative to noninfected cells within each time point. For this analysis, the AM clusters were collapsed. SARS-CoV-2 infection was found to be associated with a robust transcriptional response both at baseline and after 6mo of chronic drinking (Figure 2B). While a significant overlap between was noted between the two time points, many DEGs unique to baseline or post-ethanol consumption conditions were also identified (Figure 2B). DEGs unique to baseline enriched to processes associated with innate immunity and apoptosis (e.g. “regulation of IL1 production” and “apoptotic signaling pathway”) (Figure 2C). Some of the notable unique DEG include cathepsin D (CTSD), metalloproteases (MMP2 and MMP4) as well viral restriction factors (TRIM36, IFI35) and regulatory molecules (TREM1) (Figure 2D). On the other hand, DEGs unique to post ethanol consumption enriched to gene ontology (GO) terms “monosaccharide binding” and “response to wounding” including MIF, SERPINA1, LCN2, CCL2, and IDO1 (Figure 2C,D). Within the infiltrating monocytes, a greater number of genes enriched to GO terms “defense response to virus” and “positive regulation of type I IFN” (Figure 2C). DEG unique to the 6mo time point include TXNIP, IDO1, CC4L1, and C1Q in line with heightened TLR signaling pathways (Figure 2E).
Although T cells were not the primary target of SARS-CoV-2 (Fig 1F), transcriptional responses to infection were noted (Supp. Fig 2C, D). DEGs that play a role in type I and II interferon and anti-viral pathways were more evident at baseline. Those detected only after chronic drinking enriched primarily to apoptotic pathways (Sup Fig 2C, D). Overall, these findings indicate that ethanol consumption skews the transcriptional profiles of alveolar cells towards a hyperinflammatory state while antiviral responses are dampened.
Dysregulation of anti-SARS-CoV-2 response by AUD in humans
To place the observations obtained from the NHP model after 6 months of drinking in the context of long-term chronic heavy drinking in humans, BAL samples were obtained from individuals with AUD and smoking or smoking only (n=3/group) (Table 2). Flow cytometry revealed a significant increase in the B cell population within the control group compared to the AUD group (Table 3). Transcriptional responses to ethanol consumption were assessed by scRNA-Seq. Using canonical gene markers, we identified 6 AM clusters (MARCO, HLA-DMA, C1QA, GCGR3A, FABP4, OASL) with one of the clusters being a Proliferating AM cluster (MKI67), 2 infiltrating monocyte clusters (CCL2, CXCL8, CD14,), 1 DC cluster (CCR7, LAMP5), and 1 CD8 T cell cluster (CD3D, CD8A, CD8B, GZMA) (Figures 3A, B). The clusters were distributed among all samples and timepoints (Supp. Fig 4A). The 5 non-proliferating AM clusters were found to be distinct based on unique expression patterns of CXCL15, IL1B, FOS, CD14, SLC3A2, ARK1C3, FN1, FBP1, LIPA, CAQB, CTSD, HLA-DQB1, CXCL8, ATF3, OASL (Supp. Fig 4B).
Table 3:
Frequencies of immune cell populations determined by flow cytometery
Cell type | Control (%) | AUD (%) | Derived | ||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 1 | 2 | 3 | ||
AM | 61.7 | 74.1 | 80.9 | 72.6 | 86.1 | 53.6 | % of Live Cells |
AM 163− | 90.5 | 90.8 | 95.3 | 85.7 | 89 | 90.2 | % of Live AM |
AM 163+ | 6.55 | 6.91 | 3.02 | 12.3 | 9.1 | 5.67 | % of Live AM |
IM | 5.87 | 5.21 | 5.03 | 7.76 | 4.38 | 12.6 | % of Live Cells |
DC | 1.88 | 2.26 | 0.37 | 3.15 | 0.6 | 1.33 | % of Live Cells |
Monocytes | 1.18 | 3.09 | 0.79 | 3.74 | 0.51 | 1.71 | % of Live Cells |
Classical Monocytes | 97.6 | 98.3 | 97 | 98.9 | 95.4 | 94.5 | % of Live Monocytes |
Non-classical Monocytes | 2.41 | 1.67 | 2.95 | 1.09 | 4.6 | 5.54 | % of Live Monocytes |
CD4+ | 15.4 | 18.4 | 5.99 | 17.1 | 30.9 | 8.96 | % of Live Cells |
CD8+ | 27.3 | 17.2 | 5.55 | 27.6 | 4.8 | 9.47 | % of Live Cells |
NK | 1.48 | 2.52 | 2.69 | 2.4 | 1.67 | 3.18 | % of Live Cells |
B Cells* | 0.74 | 1.01 | 0.67 | 0.15 | 0.38 | 0.46 | % of Live Cells |
significant difference in cell populations when comparing the control group to the AUD group.
Figure 3: Alcohol consumption in humans dysregulates immune responses to SARS-CoV-2.
A) UMAP visualization of 12,083 cells from both control and alcohol cohorts prior to and after SARS-CoV-2 stimulation. B) Bubble plot of canonical marker genes used to identify cell clusters. Percent of cells that express each transcript is represented by the size of the bubble while the average expression of those cells is denoted by color, ranging from blue (low) to red (high). C) Barplot of immune mediator production stratified by condition and timepoint (trending p ≤ 0.1) (EtOH non-infected, Control SARS, and EtOH SARS n=3; Control non-infected n=2). D) Cluster frequency stratified by condition and timepoint. E) Average expression of SARS-CoV-2 in the UMAP and compared between control and AUD groups. F) Bubbleplot of SARS-CoV-2 expression within each cluster stratified by timepoint. Average expression of the SARS-CoV-2 transcript is represented by bubble size while the significance of expression when comparing baseline to 6 months is denoted by color. G) Comparison of module scores of genes mapped to TLR signaling, cytokine/chemokine signaling, and viral/bacterial response, stratified by stimulation condition and collection timepoint. (* p ≤ 0.05, trending p ≤ 0.1).
Similar to NHP, ethanol consumption resulted in transcriptional alteration of immune cell populations within the BAL. There was an increase in scores of modules associated with migration, oxidative stress, hypoxia, and signaling pathways (TLR, cytokine/chemokine, NFKB, HIF-1α) within myeloid cell populations (AM and monocytes) (Supp. Fig 5A). Furthermore, DEGs in myeloid populations after ethanol consumption mapped to GO terms such as inflammatory response (CXCL1, CXCL3, FN1, LYZ) and positive regulation of cytokine production (CD36, CD84, IL-1α) (Supp. Fig 5B,C). DEGs such as GNLY, CCL4, and GZMB were detected within lymphoid subsets (CD8) (Supp. Figure 5C).
Following SARS-CoV-2 infection, AUD was associated with modest increases in the secretion of cytokines, chemokines, and growth factors (PDGF-BB, IL-7, VEGF, IL-18, IL-15, CXCL10, CCL11) whereas infection of BAL cells from non-AUD individuals did not lead to a significant production of immune mediators (Figure 3C, Supp Table 1). Infection with SARS-CoV-2 did not lead to significant alterations in cluster frequency other than a modest increase in AM1 in the control group (Figure 3D).
As described for the macaque samples, SARS-CoV-2 transcripts were primarily detected in AM and infiltrating monocyte populations (Figure 3E, F). In all AM clusters, except for AM5 and proliferating AM, the expression of SARS-CoV-2 transcripts was higher in the AUD group compared to controls with viral transcripts more abundant in Mono1, Mono2, and DC (Figure 3E, F). Module scores associated with TLR and cytokine/chemokine signaling were increased in the SARS-CoV-2 infected AUD samples of AM2 and Mono2 cells respectively (Figure 3G). Overall, DEGs in the AUD group played critical roles in anti-viral, inflammatory, and oxidative stress responses (Supp. Fig 4C). Interestingly, several genes had different expression patterns with infection in AUD samples including ISG (ISG20, IFI6), cytokines (IL6, TNF), and chemokines (CXCL2, CXCL3, CCL22, CXCL10) (Supp. Figure 4D).
DISCUSSION
Chronic heavy drinking has been associated with increased incidence and severity of respiratory infections (47–49). Shelter-in-place orders during the COVID-19 pandemic have led to increased alcohol consumption in the United States (41). It has been hypothesized that chronic alcohol consumption negatively impacts COVID-19 outcomes (50). However, this question has yet to be investigated in greater detail. Thus, in this study, we investigated the cellular and transcriptional impact of chronic alcohol consumption on responses to SARS-CoV-2 infection using BAL samples from female and male rhesus macaques that self-administered ethanol for six months (6, 51–54) and human male subjects with AUD.
In macaques, most immune cell populations decreased in relative frequency following six months of ethanol consumption, with the exception of AM. The increase in the relative frequency of AM was more pronounced in male macaques, which is in accordance with data from rodent models (55). Moreover, ethanol consumption led to a shift toward inflammatory AM and non-classical monocytes in line with heightened inflammation (3, 28, 51, 56). We also report that chronic ethanol consumption skews the immune landscape towards inflammatory responses, as indicated by increased expression of genes within the HIF1α as well as TLR signaling pathways.
SARS-CoV-2 transcripts were primarily detected within myeloid subsets in BAL. These observations align with earlier studies that have reported the detection of SARS-CoV-2 viral RNA or transcripts in BAL (57–59) as well as scRNA-seq analysis of whole lung tissue that reported SARS-CoV-2 viral reads within macrophage, endothelial, DC, and monocyte populations (59). Studies have also shown that AM can express ACE2 (60, 61) and TMPRSS (61), both required for SARS-CoV-2 infection. However, it remains unclear whether monocytes/macrophages can support SARS-CoV-2 replication or whether the presence of the SARS-CoV-2 transcripts is simply a consequence of phagocytosis of dying infected cells or viral particles (62).
In line with the detection of SARS-CoV-2 transcripts, the most significant transcriptional differences after infection were detected within myeloid subsets. Chronic ethanol consumption led to greater induction of TLR signaling pathways in line with previous studies that showed chronic inflammation increases oxidative stress and activates TLR signaling cascades (63, 64). In contrast, after 6 months of chronic drinking, the induction of genes important for anti-viral responses was reduced across multiple subsets compared to baseline. Reduced ISG expression could be a result of reduced production of IFNβ. These data are similar to those from previous studies using the same rhesus macaque model of self-administration, which reported heightened proinflammatory responses and dampened expression of ISG in AM subsets in response to RSV infection (3). Decreased production of immune mediators involved in tissue repair mechanisms, such as VEGF, suggests a decreased tissue repair capacity (65). Reduced antiviral responses and tissue repair capacity may explain the exacerbated SARS-CoV-2 disease severity documented among AUD patients (66).
Although T cells harbored very few SARS-CoV-2 transcripts, the expression of genes important for chemotaxis, anti-viral responses, cytokine signaling, and apoptosis were altered. These transcriptional responses are likely secondary to the inflammatory responses generated by the myeloid cells after CHD and align with previous reports of impaired T cell function after alcohol exposure (67–69). The lack of induction of genes mapping to leukocyte migration could be explained by the decrease in T-cell chemoattractant IL-15 following CHD (70).
Myeloid cells were also the predominant cell type to harbor SARS-CoV-2 transcripts in BAL samples from humans with AUD. However, inflammatory mediators were produced at greater levels in samples from individuals with AUD compared to the control smoking group only. This differs from the data obtained with NHP control BAL samples which were obtained before beginning of ethanol self-administration, suggesting that smoking may abrogate inflammatory responses. Indeed, previous work has shown that tobacco smoking reduces both gene expression and production of proinflammatory cytokines (TNFα, IL-1β, and IL-16) in alveolar macrophages stimulated with TLR2 and TLR4 agonists (71). Additional studies utilizing electrochemiluminescence techniques to measure immune mediator production indicated that CHD, without concomitant smoking, produced the most robust inflammatory cytokine response (IFN-γ, IL-1β, and IL-6) and smoking with AUD resulted in decreased AM immune mediator responses to bacterial stimuli (72).
In summary, we show that CHD results in the dysregulation of SARS-CoV-2 response pathways. The innate branch of the immune system has proven to be a key component in modulating both SARS-CoV-2 disease severity and clinical outcomes (73). CHD reprograms innate immune cells, skewing their ability to respond to pathogens appropriately and efficiently by decreasing antiviral cytokines and transcriptionally altering the viral recognition and response pathways. Such reprogramming can induce aberrant inflammation and reduced antimicrobial responses (53). Our study supports this conclusion with the demonstration that impaired response to pathogens involves CHD-induced transcriptional changes that then increase both susceptibility and severity of SARS-CoV-2 infection.
Supplementary Material
Acknowledgments:
We could like to thank Dr. Delphine Malherbe for critical reading of the manuscript, all the members of Dr. Kathy Grant for expert aniamal care, the Division of Comparative Medicine at the Oregon National Primate Center for sample collection, and Dr. Ellen Burnham’s team for providing human BAL samples.
This study was supported by NIH 1R01AA028735-04 (Messaoudi), U01AA013510-20 (Grant), R24AA019431-14 (Grant), and R24AA019661 (Burnham). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Footnotes
Competing interests:
There are no competing interests to report.
References
- 1.Alcoholism NIoAAa. Understanding alcohol use disorder. 2020. Available from: https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/understanding-alcohol-use-disorder.
- 2.SAMHSA CfBHSaQ. Table 5.4a – alcohol use disorder in past year among persons aged 12 or older, by age group and demographic characteristics: Numbers in thousands, 2018 and 2019. 2019. Available from: https://www.samhsa.gov/data/sites/default/files/reports/rpt29394/NSDUHDetailedTabs2019/NSDUHDetTabsSect5pe2019.htm#tab5-4a.
- 3.Lewis SA, Doratt BM, Sureshchandra S, Jankeel A, Newman N, Shen W, Grant KA, Messaoudi I. Ethanol consumption induces nonspecific inflammation and functional defects in alveolar macrophages. Am J Respir Cell Mol Biol 2022;67(1):112–124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bruha R, Dvorak K, Petrtyl J. Alcoholic liver disease. World J Hepatol 2012;4(3):81–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Detlefsen S, Sipos B, Feyerabend B, Klöppel G. Fibrogenesis in alcoholic chronic pancreatitis: The role of tissue necrosis, macrophages, myofibroblasts and cytokines. Mod Pathol 2006;19(8):1019–1026. [DOI] [PubMed] [Google Scholar]
- 6.Sureshchandra S, Stull C, Ligh BJK, Nguyen SB, Grant KA, Messaoudi I. Chronic heavy drinking drives distinct transcriptional and epigenetic changes in splenic macrophages. EBioMedicine 2019;43:594–606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.O’Keefe JH, Bhatti SK, Bajwa A, DiNicolantonio JJ, Lavie CJ. Alcohol and cardiovascular health: The dose makes the poison…or the remedy. Mayo Clin Proc 2014;89(3):382–393. [DOI] [PubMed] [Google Scholar]
- 8.Mukamal KJ, Rimm EB. Alcohol’s effects on the risk for coronary heart disease. Alcohol Res Health 2001;25(4):255–261. [PMC free article] [PubMed] [Google Scholar]
- 9.Rumgay H, Shield K, Charvat H, Ferrari P, Sornpaisarn B, Obot I, Islami F, Lemmens VEPP, Rehm J, Soerjomataram I. Global burden of cancer in 2020 attributable to alcohol consumption: A population-based study. The Lancet Oncology 2021;22(8):1071–1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Freedman ND, Schatzkin A, Leitzmann MF, Hollenbeck AR, Abnet CC. Alcohol and head and neck cancer risk in a prospective study. British Journal of Cancer 2007;96(9):1469–1474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A, Green J. Moderate alcohol intake and cancer incidence in women. JNCI Journal of the National Cancer Institute 2009;101(5):296–305. [DOI] [PubMed] [Google Scholar]
- 12.Smothers BA, Yahr HT. Alcohol use disorder and illicit drug use in admissions to general hospitals in the united states. American Journal on Addictions 2005;14(3):256–267. [DOI] [PubMed] [Google Scholar]
- 13.de Wit M, Zilberberg MD, Boehmler JM, Bearman GM, Edmond MB. Outcomes of patients with alcohol use disorders experiencing healthcare-associated infections. Alcohol Clin Exp Res 2011;35(7):1368–1373. [DOI] [PubMed] [Google Scholar]
- 14.Delgado-Rodríguez M, Gómez-Ortega A, Mariscal-Ortiz M, Palma-Pérez S, Sillero-Arenas M. Alcohol drinking as a predictor of intensive care and hospital mortality in general surgery: A prospective study. Addiction 2003;98(5):611–616. [DOI] [PubMed] [Google Scholar]
- 15.Trevejo-Nunez G, Kolls JK, de Wit M. Alcohol use as a risk factor in infections and healing: A clinician’s perspective. Alcohol Res 2015;37(2):177–184. [PMC free article] [PubMed] [Google Scholar]
- 16.Gentilello LM, Cobean RA, Walker AP, Moore EE, Wertz MJ, Dellinger EP. Acute ethanol intoxication increases the risk of infection following penetrating abdominal trauma. J Trauma 1993;34(5):669–674; discussion 674–665. [DOI] [PubMed] [Google Scholar]
- 17.Prevention CfDCa. The cost of excessive alcohol use. Available from: https://www.cdc.gov/alcohol/onlinemedia/infographics/cost-excessive-alcohol-use.html.
- 18.Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 national and state costs of excessive alcohol consumption. American Journal of Preventive Medicine 2015;49(5):e73–e79. [DOI] [PubMed] [Google Scholar]
- 19.Prevention CfDCa. Deaths from excessive alcohol use in the united states. 2022. Available from: https://www.cdc.gov/alcohol/features/excessive-alcohol-deaths.html.
- 20.Kershaw CD, Guidot DM. Alcoholic lung disease. Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism 2008;31(1):66–75. [PMC free article] [PubMed] [Google Scholar]
- 21.Jung MK, Callaci JJ, Lauing KL, Otis JS, Radek KA, Jones MK, Kovacs EJ. Alcohol exposure and mechanisms of tissue injury and repair. Alcoholism, clinical and experimental research 2011;35(3):392–399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Malherbe DC, Messaoudi I. Transcriptional and epigenetic regulation of monocyte and macrophage dysfunction by chronic alcohol consumption. Front Immunol 2022;13:911951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Szabo G, Saha B. Alcohol’s effect on host defense. Alcohol Res 2015;37(2):159–170. [PMC free article] [PubMed] [Google Scholar]
- 24.Jerrells TR, Pavlik JA, DeVasure J, Vidlak D, Costello A, Strachota JM, Wyatt TA. Association of chronic alcohol consumption and increased susceptibility to and pathogenic effects of pulmonary infection with respiratory syncytial virus in mice. Alcohol 2007;41(5):357–369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Simet SM, Sisson JH. Alcohol’s effects on lung health and immunity. Alcohol Res 2015;37(2):199–208. [PMC free article] [PubMed] [Google Scholar]
- 26.Meadows GG, Wallendal M, Kosugi A, Wunderlich J, Singer DS. Ethanol induces marked changes in lymphocyte populations and natural killer cell activity in mice. Alcohol Clin Exp Res 1992;16(3):474–479. [DOI] [PubMed] [Google Scholar]
- 27.Osterndorff-Kahanek E, Ponomarev I, Blednov YA, Harris RA. Gene expression in brain and liver produced by three different regimens of alcohol consumption in mice: Comparison with immune activation. PLoS One 2013;8(3):e59870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Burnham EL, Kovacs EJ, Davis CS. Pulmonary cytokine composition differs in the setting of alcohol use disorders and cigarette smoking. Am J Physiol Lung Cell Mol Physiol 2013;304(12):L873–882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kolls JK, Xie J, Lei D, Greenberg S, Summer WR, Nelson S. Differential effects of in vivo ethanol on lps-induced tnf and nitric oxide production in the lung. American Journal of Physiology-Lung Cellular and Molecular Physiology 1995;268(6):L991–L998. [DOI] [PubMed] [Google Scholar]
- 30.Mandrekar P, Dolganiuc A, Bellerose G, Kodys K, Romics L, Nizamani R, Szabo G. Acute alcohol inhibits the induction of nuclear regulatory factor kappab activation through cd14/toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors: A common mechanism independent of inhibitory kappabalpha degradation? Alcoholism: Clinical and Experimental Research 2002;26(11):1609–1614. [DOI] [PubMed] [Google Scholar]
- 31.Karavitis J, Kovacs EJ. Macrophage phagocytosis: Effects of environmental pollutants, alcohol, cigarette smoke, and other external factors. J Leukoc Biol 2011;90(6):1065–1078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Gandhi JA, Ekhar VV, Asplund MB, Abdulkareem AF, Ahmadi M, Coelho C, Martinez LR. Alcohol enhances acinetobacter baumannii-associated pneumonia and systemic dissemination by impairing neutrophil antimicrobial activity in a murine model of infection. PLoS One 2014;9(4):e95707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Szabo G, Mandrekar P, Catalano D. Inhibition of superantigen-induced t cell proliferation and monocyte il-1 beta, tnf-alpha, and il-6 production by acute ethanol treatment. J Leukoc Biol 1995;58(3):342–350. [DOI] [PubMed] [Google Scholar]
- 34.Joshi PC, Applewhite L, Ritzenthaler JD, Roman J, Fernandez AL, Eaton DC, Brown LA, Guidot DM. Chronic ethanol ingestion in rats decreases granulocyte-macrophage colony-stimulating factor receptor expression and downstream signaling in the alveolar macrophage. J Immunol 2005;175(10):6837–6845. [DOI] [PubMed] [Google Scholar]
- 35.Lewis SA, Doratt B, Sureshchandra S, Jankeel A, Newman N, Shen W, Grant KA, Messaoudi I. Ethanol consumption induces non-specific inflammation and functional defects in alveolar macrophages. Am J Respir Cell Mol Biol 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Staitieh BS, Egea EE, Fan X, Amah A, Guidot DM. Chronic alcohol ingestion impairs rat alveolar macrophage phagocytosis via disruption of rage signaling. Am J Med Sci 2018;355(5):497–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Guilliams M, De Kleer I, Henri S, Post S, Vanhoutte L, De Prijck S, Deswarte K, Malissen B, Hammad H, Lambrecht BN. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via gm-csf. J Exp Med 2013;210(10):1977–1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Simet SM, Wyatt TA, Devasure J, Yanov D, Allen-Gipson D, Sisson JH. Alcohol increases the permeability of airway epithelial tight junctions in beas-2b and nhbe cells. Alcoholism: Clinical and Experimental Research 2012;36(3):432–442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Liang Y, Yeligar SM, Brown LAS. Chronic-alcohol-abuse-induced oxidative stress in the development of acute respiratory distress syndrome. The Scientific World Journal 2012;2012:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Modrykamien AM, Gupta P. The acute respiratory distress syndrome. Proc (Bayl Univ Med Cent) 2015;28(2):163–171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Administration SAaMHS. 2020. national survey of drug use and health (nsduh) releases. Available from: https://www.samhsa.gov/data/release/2020-national-survey-drug-use-and-health-nsduh-releases.
- 42.Dai X-j, Tan L, Ren L, Shao Y, Tao W, Wang Y. Covid-19 risk appears to vary across different alcoholic beverages. Frontiers in Nutrition 2022;8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Baker EJ, Farro J, Gonzales S, Helms C, Grant KA. Chronic alcohol self-administration in monkeys shows long-term quantity/frequency categorical stability. Alcohol Clin Exp Res 2014;38(11):2835–2843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Grant KA, Leng X, Green HL, Szeliga KT, Rogers LS, Gonzales SW. Drinking typography established by scheduled induction predicts chronic heavy drinking in a monkey model of ethanol self-administration. Alcohol Clin Exp Res 2008;32(10):1824–1838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, et al. Integrated analysis of multimodal single-cell data. Cell 2021;184(13):3573–3587 e3529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 2019;10(1):1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bailey KL, Sayles H, Campbell J, Khalid N, Anglim M, Ponce J, Wyatt TA, McClay JC, Burnham EL, Anzalone A, et al. Covid-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality. Alcohol Clin Exp Res 2022;46(6):1023–1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Mehta AJ, Yeligar SM, Elon L, Brown LA, Guidot DM. Alcoholism causes alveolar macrophage zinc deficiency and immune dysfunction. Am J Respir Crit Care Med 2013;188(6):716–723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Yeligar SM, Chen MM, Kovacs EJ, Sisson JH, Burnham EL, Brown LA. Alcohol and lung injury and immunity. Alcohol 2016;55:51–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Testino G. Are patients with alcohol use disorders at increased risk for covid-19 infection? Alcohol Alcohol 2020;55(4):344–346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Lewis SA, Sureshchandra S, Doratt B, Jimenez VA, Stull C, Grant KA, Messaoudi I. Transcriptional, epigenetic, and functional reprogramming of monocytes from non-human primates following chronic alcohol drinking. Frontiers in Immunology 2021;12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Sureshchandra S, Raus A, Jankeel A, Ligh BJK, Walter NAR, Newman N, Grant KA, Messaoudi I. Dose-dependent effects of chronic alcohol drinking on peripheral immune responses. Scientific Reports 2019;9(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Barr T, Girke T, Sureshchandra S, Nguyen C, Grant K, Messaoudi I. Alcohol consumption modulates host defense in rhesus macaques by altering gene expression in circulating leukocytes. The Journal of Immunology 2016;196(1):182–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Barr T, Lewis SA, Sureshchandra S, Doratt B, Grant KA, Messaoudi I. Chronic ethanol consumption alters lamina propria leukocyte response to stimulation in a region-dependent manner. The FASEB Journal 2019;33(6):7767–7777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Spitzer JA. Gender differences in nitric oxide production by alveolar macrophages in ethanol plus lipopolysaccharide-treated rats. Nitric Oxide 1997;1(1):31–38. [DOI] [PubMed] [Google Scholar]
- 56.O’Halloran EB, Curtis BJ, Afshar M, Chen MM, Kovacs EJ, Burnham EL. Alveolar macrophage inflammatory mediator expression is elevated in the setting of alcohol use disorders. Alcohol 2016;50:43–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Xiong Y, Liu Y, Cao L, Wang D, Guo M, Jiang A, Guo D, Hu W, Yang J, Tang Z, et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in covid-19 patients. Emerg Microbes Infect 2020;9(1):761–770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Speranza E, Purushotham JN, Port JR, Schwarz B, Flagg M, Williamson BN, Feldmann F, Singh M, Perez-Perez L, Sturdevant GL, et al. Age-related differences in immune dynamics during sars-cov-2 infection in rhesus macaques. Life Sci Alliance 2022;5(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Speranza E, Williamson BN, Feldmann F, Sturdevant GL, Perez-Perez L, Meade-White K, Smith BJ, Lovaglio J, Martens C, Munster VJ, et al. Single-cell rna sequencing reveals sars-cov-2 infection dynamics in lungs of african green monkeys. Sci Transl Med 2021;13(578). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Wang C, Xie J, Zhao L, Fei X, Zhang H, Tan Y, Nie X, Zhou L, Liu Z, Ren Y, et al. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe covid-19 patients. EBioMedicine 2020;57:102833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Bertram S, Heurich A, Lavender H, Gierer S, Danisch S, Perin P, Lucas JM, Nelson PS, Pöhlmann S, Soilleux EJ. Influenza and sars-coronavirus activating proteases tmprss2 and hat are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS ONE 2012;7(4):e35876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Stegelmeier AA, van Vloten JP, Mould RC, Klafuric EM, Minott JA, Wootton SK, Bridle BW, Karimi K. Myeloid cells during viral infections and inflammation. Viruses 2019;11(2). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.El-Zayat SR, Sibaii H, Mannaa FA. Toll-like receptors activation, signaling, and targeting: An overview. Bulletin of the National Research Centre 2019;43(1). [Google Scholar]
- 64.Hussain T, Tan B, Yin Y, Blachier F, Tossou MC, Rahu N. Oxidative stress and inflammation: What polyphenols can do for us? Oxid Med Cell Longev 2016;2016:7432797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Eming SA, Krieg T. Molecular mechanisms of vegf-a action during tissue repair. J Investig Dermatol Symp Proc 2006;11(1):79–86. [DOI] [PubMed] [Google Scholar]
- 66.Bhalla S, Sharma B, Smith D, Boley R, McCluskey C, Ilyas Y, Afshar M, Balk R, Karnik N, Keshavarzian A. Investigating unhealthy alcohol use as an independent risk factor for increased covid-19 disease severity: Observational cross-sectional study. JMIR Public Health Surveill 2021;7(11):e33022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Kapasi AA, Patel G, Goenka A, Nahar N, Modi N, Bhaskaran M, Reddy K, Franki N, Patel J, Singhal PC. Ethanol promotes t cell apoptosis through the mitochondrial pathway. Immunology 2003;108(3):313–320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Hemann EA, McGill JL, Legge KL. Chronic ethanol exposure selectively inhibits the influenza-specific cd8 t cell response during influenza a virus infection. Alcohol Clin Exp Res 2014;38(9):2403–2413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Pasala S, Barr T, Messaoudi I. Impact of alcohol abuse on the adaptive immune system. Alcohol Res 2015;37(2):185–197. [PMC free article] [PubMed] [Google Scholar]
- 70.Wilkinson PC, Liew FY. Chemoattraction of human blood t lymphocytes by interleukin-15. J Exp Med 1995;181(3):1255–1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of il-1r-associated kinase, p38, and nf-kappab in alveolar macrophages stimulated with tlr2 and tlr4 agonists. J Immunol 2007;179(9):6097–6106. [DOI] [PubMed] [Google Scholar]
- 72.Gaydos J, McNally A, Guo R, Vandivier RW, Simonian PL, Burnham EL. Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells. Am J Physiol Lung Cell Mol Physiol 2016;310(6):L507–518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Diamond MS, Kanneganti T-D. Innate immunity: The first line of defense against sars-cov-2. Nature Immunology 2022;23(2):165–176. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets utilized in this article are available on NCBI’s Sequence Read Archive PRJNA930878 (NHP) and PRJNA930381 (Human).